Genetic Polymorphism of CYP2C19 Gene in the Stanislas Cohort. A link with Inflammation

CYP2C19, a member of the cytochrome P450 family, metabolises arachidonic acid to produce epoxyeicosanoid acids, which are involved in vascular tone and inflammation. Thus, this study describes the possible relationship between a CYP2C19 polymorphism (681G>A) and three inflammatory markers: interleukin (IL)-6, tumor necrosis factor-α (TNF-α) and high sensitivity C-reactive protein (hs-CRP) in healthy individuals.
In a sub-sample of 178 men and 181 women from the Stanislas study, we quantified plasma IL-6 and TNF-α concentrations by using an enzyme-linked immunosorbent assay, and serum hs-CRP concentration by immunonephelometry. The CYP2C19 681G>A polymorphism was genotyped using the kinetic thermocycling allele specific PCR method.
In the Stanislas cohort, the frequency of the allele CYP2C19*2 (681A) was 17.8%. Circulating levels of inflammatory factors were increased in individuals homozygous for the defective allele CYP2C19*2 (A) notably IL-6 in the whole sample ( P = 0.0008) and hs-CRP only in women ( P = 0.008), with a significant interaction with sex ( P = 0.005), in comparison to carriers of one copy or more of the wild type allele CYP2C19*1 (G). Only a trend of association ( P = 0.089) was found between this polymorphism and TNF-α concentration in the whole sample.
The association between CYP2C19*2 polymorphism and inflammatory markers' concentrations could suggest that CYP2C19 may be considered as a new candidate gene for cardiovascular risks via inflammation.